LIQUIDIA TECHNOLOGIES
Liquidia Technologies is a late-stage clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using our proprietary PRINT technology to transform the lives of patients. PRINT technology is a particle engineering platform that enables the precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. Currently, Liquidia is developing two product candidates from its own pipeline:... LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. In addition to developing our own product candidates, Liquidia collaborates with leading pharmaceutical companies to apply our PRINT technology across a wide range of therapeutic areas, molecule types, and routes of administration.
LIQUIDIA TECHNOLOGIES
Industry:
Biopharma Biotechnology Nanotechnology Therapeutics
Founded:
2004-01-01
Address:
Morrisville, North Carolina, United States
Country:
United States
Website Url:
http://www.liquidia.com
Total Employee:
11+
Status:
Active
Contact:
(919)328-4400
Total Funding:
223.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FibroGen
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
Raptor Pharmaceuticals
Raptor is a NASDAQ-listed biopharmaceutical company with the mission to develop and commercialize life-altering therapeutics.
Current Advisors List
Board_member
2007-01-01
Board_member
2008-01-01
Board_member
Board_member
Board_member
2016-09-01
Board_member
2018-06-01
Board_observer
Board_member
Current Employees Featured
Joanna C. Horobin Non Executive Director @ Liquidia Technologies
Non Executive Director
2019-09-01
Mike Kaseta Chief Financial Officer @ Liquidia Technologies
Chief Financial Officer
2020-11-01
Roger Jeffs Chief Executive Officer (CEO) @ Liquidia Technologies
Chief Executive Officer (CEO)
2022-01-01
Damian deGoa Director @ Liquidia Technologies
Director
2022-01-01
Tushar Shah Chief Medical Officer @ Liquidia Technologies
Chief Medical Officer
Bruce Boucher President & Chief Financial Officer @ Liquidia Technologies
President & Chief Financial Officer
2004-01-01
Robert Lippe COO @ Liquidia Technologies
COO
Ed Mathers Team Member @ Liquidia Technologies
Team Member
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-29 | RareGen | RareGen acquired by Liquidia Technologies | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Liquidia Technologies
Paul Manning
Paul Manning investment in Post-IPO Equity - Liquidia Technologies
Caligan Partners
Caligan Partners investment in Post-IPO Equity - Liquidia Technologies
Roger Jeffs
Roger Jeffs investment in Post-IPO Equity - Liquidia Technologies
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Liquidia Technologies
Eshelman Ventures
Eshelman Ventures investment in Post-IPO Equity - Liquidia Technologies
Samsara BioCapital
Samsara BioCapital investment in Post-IPO Equity - Liquidia Technologies
AMDG 1
AMDG 1 investment in Post-IPO Equity - Liquidia Technologies
BKB Growth Investments
BKB Growth Investments investment in Post-IPO Equity - Liquidia Technologies
Canaan Partners
Canaan Partners investment in Post-IPO Equity - Liquidia Technologies
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-03 | Liquidia Corporation Announces Chief Executive Officer Transition |
| 2020-08-20 | Liquidia Announces Chief Financial Officer Transition |
| 2020-05-18 | Morrisville-based Liquidia names its first chief medical officer |
Official Site Inspections
http://www.liquidia.com Semrush global rank: 3.31 M Semrush visits lastest month: 4.88 K
- Host name: a23-212-249-200.deploy.static.akamaitechnologies.com
- IP address: 23.212.249.200
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Liquidia Technologies"
Liquidia Corporation - LinkedIn
Liquidia Corporation | 8,765 followers on LinkedIn. A biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. | Liquidia Corporation is a ...See details»
Liquidia CSR
Liquidia is a biopharmaceutical company which core mission is to develop and deliver innovative medical products to meet unmet patient needs and help improve their lives.. We are …See details»
Corporate Overview - investors.liquidia.com
Hill N. S., et al., INSPIRE: A Phase 3 Open-Label, Multicenter Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension (PAH) – Exploratory EfficacySee details»
Liquidia Corporation (LQDA) Company Profile & Facts
Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina. Corporate Governance Liquidia Corporation’s ISS Governance QualityScore as of March 1, 2025 is 10.See details»
Investors | Liquidia Corporation
Investors | Liquidia CorporationSee details»
Liquidia Corporation Strengthens Financial Position by Amending ...
Mar 18, 2025 Under the terms of the Sixth Amendment, Liquidia will receive $25.0 million at closing with the potential to receive two additional tranches of funding: $50.0 million upon the …See details»
Events & presentations | Liquidia Corporation
Events & presentations | Liquidia CorporationSee details»
Liquidia Technologies - Crunchbase Company Profile
Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics. New. Resources. ... Experience the new Crunchbase, powered by AI . Organization. Liquidia …See details»
Liquidia Corporation Strengthens Financial Position by
Mar 18, 2025 Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans …See details»
Liquidia Corporation Company Overview, Contact Details
Feb 20, 2018 Liquidia Corporation 's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541330 - Engineering Services. How many employees does Liquidia …See details»
Liquidia secures $100 million in new financing
Jan 5, 2024 Morrisville-based Liquidia Corp., which is pursuing final regulatory approval for Yutrepia, its treatment for pulmonary arterial hypertension, has secured two agreements that …See details»
Liquidia Corp, LQDA:NAQ profile - FT.com - Financial Times
Feb 25, 2025 Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient …See details»
Liquidia CSR
Feb 16, 2024 Liquidia is a biopharmaceutical company which core mission is to develop and deliver innovative medical products to meet unmet patient needs and help improve their lives.. …See details»
Liquidia Corporation to Report Full Year 2024 Financial
Mar 12, 2025 Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans …See details»
Damian deGoa | Board Member | Liquidia Corporation
Mr. deGoa served as the COO of OA Private Capital, a family office investment firm focused on private equity investments from 2022 to 2024 and was CEO of Liquidia Corporation from …See details»
Technology | Liquidia Corporation
Uniform size and shape. The benefits of uniformly shaped and sized drug particles for inhaled delivery: Targeted delivery to the site of the disease 1. Drug particles <2 μm have greater …See details»
Liquidia Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Liquidia has 3 employees at their 1 location and $8.07 m in annual revenue in FY 2019. See insights on Liquidia including office locations, competitors, revenue, financials, …See details»
Liquidia Corporation Strengthens Financial Position by Amending ...
Mar 18, 2025 Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans …See details»
Liquidia Corporation Strengthens Financial Position by Amending ...
MORRISVILLE, N.C., March 18, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare …See details»
Liquidia Corporation Advances YUTREPIAâ„¢ Towards Final FDA
Mar 19, 2025 Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans …See details»